Laboratory Corporation of America Holdings Financials

Market Capitalization $20.43 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	46.27
Forward PE	15.25
Price to Sales TTM	$1.61
Price to Book MRQ	$2.50
Enterprise to Revenue	2.10
Enterprise to EBITDA	15.96

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	3.43%
Operating Margin	8.29%
Return on Assets TTM	3.96%
Return on Equity TTM	5.43%

Income Statement

Revenue TTM	$12,712,800,256
Revenue per Share TTM	$151.03
Quarterly Revenue Growth	7.40%
Gross Profit TTM	$3,549,499,904
EBITDA	$1,809,700,000
Net Income to Common TTM	$435,500,000
Diluted EPS TTM	$5.28
Quarterly Earnings Growth YoY	-7.60%

Balance Sheet

Total Cash MRQ	$1,517,299,968
Total Cash per Share MRQ	$18.14
Total Debt MRQ	$
Total Debt to Equity MRQ	95.00
Current Ratio MRQ	1.44
Book Value per Share MRQ	$97.61

Cash Flow

Operating Cash Flow TTM	$1,388,199,936
Levered Free Cash Flow TTM	$694,400,000

LH Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	83,639,296
Float Shares	83,233,611
Avg 10 Volume	564,330
Avg 30 Volume	None
Shares Short	1,921,215
Short Ratio	4.06
Short % of Shares	3.06%
% Held by Insiders	0.33%
% Held by Institutions	94.68%

Stock Price Summary

Beta	1.04
Fifty Two Week Low	$191.97
Fifty Two Week High	$247.99
Fifty Two Week Change	7.67%
Day 50 MA	$235.56
Day 200 MA	$219.02

Dividends and Splits

Forward Annual Dividend Rate	$2.88
Forward Annual Dividend Yield	1.17%
Trailing Annual Dividend Rate	$2.88
Trailing Annual Dividend Yield	1.17%
Payout Ratio	54.65%
Dividend Date	2025-03-12
Ex Dividend Date	2025-02-27
Last Split Factor
Last Split Date	2023-07-03